Results 11 to 20 of about 32,229 (219)

How Sodium and Calcium Ions Pass Through Batrachotoxin-Bound Sodium Channel [PDF]

open access: yesToxins
Steroidal sodium channel agonist batrachotoxin (BTX), one of the most potent animal toxins, dramatically increases calcium permeation and alters other channel characteristics.
Boris S. Zhorov
doaj   +2 more sources

The Comparative Effectiveness of Botulinum Toxin-A Injection Therapy Versus Augmentation Uretero-Enterocystoplasty for the Treatment of Lower Urinary Tract Dysfunction [PDF]

open access: yesInternational Neurourology Journal, 2023
Purpose We investigated the effectiveness of intravesical botulinum toxin-A (BTX-A) injection therapy in patients with lower urinary tract dysfunction (LUTD) and upper urinary tract (UUT) deterioration and evaluated whether BTX-A injection therapy could ...
Xuesheng Wang, Zhonghan Zhou, Limin Liao
doaj   +1 more source

Counting Process Based Dimension Reduction Methods for Censored Outcomes [PDF]

open access: yes, 2018
We propose a class of dimension reduction methods for right censored survival data using a counting process representation of the failure process. Semiparametric estimating equations are constructed to estimate the dimension reduction subspace for the ...
Sun, Qiang   +3 more
core   +3 more sources

Snake and spider toxins induce a rapid recovery of function of botulinum neurotoxin paralysed neuromuscular junction [PDF]

open access: yes, 2015
Botulinum neurotoxins (BoNTs) and some animal neurotoxins (-Bungarotoxin, -Btx, from elapid snakes and -Latrotoxin, -Ltx, from black widow spiders) are pre-synaptic neurotoxins that paralyse motor axon terminals with similar clinical outcomes in patients.
Duregotti, Elisa   +6 more
core   +2 more sources

Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2/MyD88 and SNAP23

open access: yesCell & Bioscience, 2020
Background Botulinum toxin type A (BTX-A) was considered to be a new potential drug for neuropathic pain (NP) treatment. Results In vivo, BTX-A attenuated chronic compression injury (CCI)-induced pain in rats, and reduced production of pro-inflammatory ...
Xuan Wang   +7 more
doaj   +1 more source

Effect of Botulinum Toxin A on Bladder Pain—Molecular Evidence and Animal Studies

open access: yesToxins, 2020
Botulinum toxin A (BTX-A) is a powerful neurotoxin with long-lasting activity that blocks muscle contractions. In addition to effects on neuromuscular junctions, BTX-A also plays a role in sensory feedback loops, suggesting the potentiality for pain ...
Ting-Chun Yeh   +3 more
doaj   +1 more source

Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study

open access: yesBMC Musculoskeletal Disorders, 2017
Background Botulinum toxin A (BTX-A) has been used to reduce spasticity in children with cerebral palsy (CP) for decades. The purpose of this study was to analyze to what extent BTX-A treatment was used to treat spasticity in a total population of ...
Maria Franzén   +2 more
doaj   +1 more source

Differential Contribution of Subunit Interfaces to α 9 α 10 Nicotinic Acetylcholine Receptor Function [PDF]

open access: yes, 2017
Nicotinic acetylcholine receptors can be assembled from either homomeric or heteromeric pentameric subunit combinations. At the interface of the extracellular domains of adjacent subunits lies the acetylcholine binding site, composed of a principal ...
Boffi, Juan Carlos   +11 more
core   +3 more sources

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis

open access: yesRenal Failure, 2019
The aim of this work was to evaluate the efficacy and safety of botulinum toxin A (BTX-A) treatment in patients with neurogenic detrusor overactivity.
Shang-Jun Wu   +6 more
doaj   +1 more source

Comparison of the effects of modified constraint-induced movement therapy and intensive conventional therapy with a botulinum-a toxin injection on upper limb motor function recovery in patients with stroke

open access: yesLibyan Journal of Medicine, 2019
Stroke is the second leading cause of mortality worldwide and one of the main causes of adult disability. Many studies have suggested that combination therapies provide better outcomes in patients with stroke than monotherapies.
Mohammad Nasb   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy